Monika Graeser

De-Escalated Neoadjuvant Trastuzumab-Emtansine With or Without Endocrine Therapy Versus Trastuzumab With Endocrine Therapy in HR+/HER2+ Early Breast Cancer: 5-Year Survival in the WSG-ADAPT-TP Trial

Nadia Harbeck, Ulrike Nitz, Matthias Christgen et al. · Journal of Clinical Oncology · 2023 · 33 citations

Immune cell composition and functional marker dynamics from multiplexed immunohistochemistry to predict response to neoadjuvant chemotherapy in the WSG-ADAPT-TN trial

Monika Graeser, Friedrich Feuerhake, Oleg Gluz et al. · Journal for ImmunoTherapy of Cancer · 2021 · 25 citations · Full text

Magnetic resonance imaging and ultrasound for prediction of residual tumor size in early breast cancer within the ADAPT subtrials

Monika Graeser, Simone Schrading, Oleg Gluz et al. · Breast Cancer Research · 2021 · 21 citations · Full text

Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR− Trial

Monika Graeser, Oleg Gluz, Claudia Biehl et al. · Clinical Cancer Research · 2022 · 13 citations · Full text

Early response by <scp>MR</scp> imaging and ultrasound as predictor of pathologic complete response to 12‐week neoadjuvant therapy for different early breast cancer subtypes: Combined analysis from the <scp>WSG ADAPT</scp> subtrials

Monika Graeser, Simone Schrading, Oleg Gluz et al. · International Journal of Cancer · 2021 · 11 citations · Full text